Cargando…

Inhibition of USP28 overcomes Cisplatin-resistance of squamous tumors by suppression of the Fanconi anemia pathway

Squamous cell carcinomas (SCC) frequently have an exceptionally high mutational burden. As consequence, they rapidly develop resistance to platinum-based chemotherapy and overall survival is limited. Novel therapeutic strategies are therefore urgently required. SCC express ∆Np63, which regulates the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prieto-Garcia, Cristian, Hartmann, Oliver, Reissland, Michaela, Fischer, Thomas, Maier, Carina R., Rosenfeldt, Mathias, Schülein-Völk, Christina, Klann, Kevin, Kalb, Reinhard, Dikic, Ivan, Münch, Christian, Diefenbacher, Markus E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901929/ https://www.ncbi.nlm.nih.gov/pubmed/34611298 http://dx.doi.org/10.1038/s41418-021-00875-z

Ejemplares similares

USP28 enables oncogenic transformation of respiratory cells, and its inhibition potentiates molecular therapy targeting mutant EGFR, BRAF and PI3K
por: Prieto‐Garcia, Cristian, et al.
Publicado: (2022)

Maintaining protein stability of ∆Np63 via USP28 is required by squamous cancer cells
por: Prieto‐Garcia, Cristian, et al.
Publicado: (2020)

USP28 controls SREBP2 and the mevalonate pathway to drive tumour growth in squamous cancer
por: Maier, Carina R., et al.
Publicado: (2023)

USP28: Oncogene or Tumor Suppressor? A Unifying Paradigm for Squamous Cell Carcinoma
por: Prieto-Garcia, Cristian, et al.
Publicado: (2021)

PTEN mutant non-small cell lung cancer require ATM to suppress pro-apoptotic signalling and evade radiotherapy
por: Fischer, Thomas, et al.
Publicado: (2022)

A novel classification of hematologic conditions in patients with Fanconi anemia
por: Behrens, Yvonne Lisa, et al.
Publicado: (2021)

Mutated Fanconi anemia pathway in non-Fanconi anemia cancers
por: Shen, Yihang, et al.
Publicado: (2015)

Map of synthetic rescue interactions for the Fanconi anemia DNA repair pathway identifies USP48
por: Velimezi, Georgia, et al.
Publicado: (2018)

Planispine A Sensitized Cancer Cells to Cisplatin by Inhibiting the Fanconi Anemia Pathway
por: Singh, Thangjam Davis, et al.
Publicado: (2022)

Cancer in Children With Fanconi Anemia and Ataxia-Telangiectasia—A Nationwide Register-Based Cohort Study in Germany
por: Dutzmann, Christina M., et al.
Publicado: (2022)

Non-specific chemical inhibition of the Fanconi anemia pathway sensitizes cancer cells to cisplatin
por: Jacquemont, Céline, et al.
Publicado: (2012)

The Fanconi anemia pathway and ubiquitin
por: Jacquemont, Céline, et al.
Publicado: (2007)

Phenylbutyrate interferes with the Fanconi anemia and BRCA pathway and sensitizes head and neck cancer cells to cisplatin
por: Burkitt, Kyunghee, et al.
Publicado: (2008)

The 13th Fanconi Anemia Gene Identified: FANCI – Importance of the ‘Fanconi Anemia Pathway’ for Cellular Oncology
por: Meijer, Gerrit A.
Publicado: (2007)

Fanconi anemia - learning from children
por: Svahn, Johanna, et al.
Publicado: (2011)

Honey, chromosomal breakage and fanconi anemia
por: Wiwanitkit, Somsri, et al.
Publicado: (2012)

The Fanconi Anemia Pathway of Genomic Maintenance
por: Levitus, Marieke, et al.
Publicado: (2006)

Oral lesions associated with Fanconi anemia
por: Stoopler, Eric T., et al.
Publicado: (2017)

Focal Point of Fanconi Anemia Signaling
por: Zhan, Sudong, et al.
Publicado: (2021)

Analysis of baseline and cisplatin-inducible gene expression in Fanconi anemia cells using oligonucleotide-based microarrays
por: Waisfisz, Quinten, et al.
Publicado: (2002)

Fanconi anemia and vaginal squamous cell carcinoma
por: Dias, Altamiro Ribeiro, et al.
Publicado: (2012)

Diagnosis of Fanconi Anemia: Chromosomal Breakage Analysis
por: Oostra, Anneke B., et al.
Publicado: (2012)

Mutations of the SLX4 gene in Fanconi anemia
por: Kim, Yonghwan, et al.
Publicado: (2011)

Update of the human and mouse Fanconi anemia genes
por: Dong, Hongbin, et al.
Publicado: (2015)

Current and emerging therapeutic strategies for Fanconi anemia
por: Shukla, Pallavi, et al.
Publicado: (2012)

Recent advances in understanding hematopoiesis in Fanconi Anemia
por: Bagby, Grover
Publicado: (2018)

Cutaneous Manifestations of Fanconi's Anemia in Two Siblings
por: Singh, Satyendra K., et al.
Publicado: (2017)

Maintenance of genome stability by Fanconi anemia proteins
por: Palovcak, Anna, et al.
Publicado: (2017)

Structure of the Fanconi anemia monoubiquitin ligase complex
por: Shakeel, Shabih, et al.
Publicado: (2019)

Type-I Interferon Signaling in Fanconi Anemia
por: Landelouci, Karima, et al.
Publicado: (2022)

Management of oral leukoplakia in patients with Fanconi anemia
por: Pippi, Roberto, et al.
Publicado: (2022)

Fanconi Anemia: A Rare Genetic Disorder
por: Thakur, Bharati, et al.
Publicado: (2023)

DNA requirement in FANCD2 deubiquitination by USP1-UAF1-RAD51AP1 in the Fanconi anemia DNA damage response
por: Liang, Fengshan, et al.
Publicado: (2019)

WIP1 Contributes to the Adaptation of Fanconi Anemia Cells to DNA Damage as Determined by the Regulatory Network of the Fanconi Anemia and Checkpoint Recovery Pathways
por: Rodríguez, Alfredo, et al.
Publicado: (2019)

Chronic treatment with cisplatin induces chemoresistance through the TIP60-mediated Fanconi anemia and homologous recombination repair pathways
por: Su, Wen-Pin, et al.
Publicado: (2017)

Regulation of Rev1 by the Fanconi Anemia Core Complex
por: Kim, Hyungjin, et al.
Publicado: (2012)

A Molecular, Genetic, and Diagnostic Spotlight on Fanconi Anemia
por: Hays, Laura E., et al.
Publicado: (2012)

Targeted gene therapy and cell reprogramming in Fanconi anemia
por: Rio, Paula, et al.
Publicado: (2014)

Damaged mitochondria and overproduction of ROS in Fanconi anemia cells
por: Lyakhovich, Alex
Publicado: (2013)

Dysregulated Ca(2+) Homeostasis in Fanconi anemia cells
por: Usai, Cesare, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_nvnsjtmg476jkl1f3ft54g293q